Urovant Sciences Appoints Keith A. Katkin as Chief Executive Officer

Former CEO of Avanir Pharmaceuticals joins Roivant family of companies Plans to initiate confirmatory Phase 3 program of vibegron by early 2018 BASEL, Switzerland, Sept. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Urovant Sciences, a globa... Biopharmaceuticals, Urology, Personnel Urovant Sciences, Vibegron
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news